Marshall Wace
TXG icon

Marshall Wace’s 10x Genomics TXG Stock Holding History

Marshall Wace’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Buy
102,272
+10,572
+12% +$211K ﹤0.01% 1736
2025
Q4 		$1.5M Buy
91,700
+40,701
+80% +$615K ﹤0.01% 1728
2025
Q3 		$596K Sell
50,999
-348,703
-87% -$4.55M ﹤0.01% 2163
2025
Q2 		$4.63M Sell
399,702
-17,749
-4% -$162K 0.01% 1175
2025
Q1 		$3.64M Buy
417,451
+370,590
+791% +$4.67M ﹤0.01% 1200
2024
Q4 		$673K Sell
46,861
-420,262
-90% -$6.63M ﹤0.01% 1917
2024
Q3 		$10.5M Buy
467,123
+431,722
+1,220% +$8.93M 0.01% 743
2024
Q2 		$689K Buy
+35,401
New +$927K ﹤0.01% 1835
2024
Q1 		– Sell
-7,516
Closed -$421K – 2808
2023
Q4 		$421K Buy
+7,516
New +$327K ﹤0.01% 1778
2023
Q3 		– Sell
-197,321
Closed -$11M – 2699
2023
Q2 		$11M Buy
+197,321
New +$10.7M 0.02% 689
2023
Q1 		– Sell
-19,268
Closed -$702K – 3114
2022
Q4 		$702K Buy
+19,268
New +$630K ﹤0.01% 2231
2022
Q1 		– Sell
-9,704
Closed -$1.45M – 4036
2021
Q4 		$1.45M Sell
9,704
-287,639
-97% -$44.1M ﹤0.01% 2261
2021
Q3 		$43.3M Buy
+297,343
New +$51M 0.18% 100
2021
Q1 		– Sell
-257,149
Closed -$36.4M – 2869
2020
Q4 		$36.4M Buy
257,149
+165,325
+180% +$24M 0.2% 107
2020
Q3 		$11.4M Buy
91,824
+72,924
+386% +$7.65M 0.07% 262
2020
Q2 		$1.69M Sell
18,900
-39,859
-68% -$3.1M 0.01% 847
2020
Q1 		$3.66M Buy
+58,759
New +$4.59M 0.04% 461

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's TXG Position: Q1 2026 in Review

Marshall Wace increased its 10x Genomics (TXG) stake by 12% in Q1 2026, buying an estimated $211K and bringing the position to 102,272 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1736.

Marshall Wace first reported a position in TXG in Q1 2020 and has held it in 17 quarters since. The position peaked at $43.3M in Q3 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Marshall Wace held 102,272 shares of 10x Genomics worth $2.17M as of Q1 2026.
  • Marshall Wace bought 10,572 10x Genomics shares in Q1 2026, an estimated $211K.
  • 10x Genomics made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1736 holding.
  • Marshall Wace first reported a position in 10x Genomics in Q1 2020 and has held it in 17 quarters since.
  • Marshall Wace's 10x Genomics position peaked at $43.3M in Q3 2021.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.